語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Developing costimulatory molecules f...
~
Mir, Manzoor Ahmad,
Developing costimulatory molecules for immunotherapy of diseases[electronic resource] /
紀錄類型:
書目-電子資源 : Monograph/item
杜威分類號:
616.079
書名/作者:
Developing costimulatory molecules for immunotherapy of diseases/ Manzoor Ahmad Mir.
作者:
Mir, Manzoor Ahmad,
出版者:
London : : Academic Press is an imprint of Elsevier,, ©2015.
面頁冊數:
1 online resource : : col. ill.
標題:
Immunologic diseases - Treatment.
標題:
Cellular therapy.
標題:
Immunotherapy.
標題:
Immunotherapy - methods.
標題:
Antibodies - metabolism
標題:
B7 Antigens - metabolism.
標題:
Antigen-Antibody Reactions - immunology.
ISBN:
9780128026755 (electronic bk.)
ISBN:
0128026758 (electronic bk.)
ISBN:
9780128025857
ISBN:
0128025859
書目註:
Includes bibliographical references and index.
摘要、提要註:
Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles an.
電子資源:
https://
www.sciencedirect.com/science/book/9780128025857
Developing costimulatory molecules for immunotherapy of diseases[electronic resource] /
Mir, Manzoor Ahmad,
Developing costimulatory molecules for immunotherapy of diseases
[electronic resource] /Manzoor Ahmad Mir. - London :Academic Press is an imprint of Elsevier,©2015. - 1 online resource :col. ill.
Includes bibliographical references and index.
Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles an.
ISBN: 9780128026755 (electronic bk.)Subjects--Topical Terms:
716285
Immunologic diseases
--Treatment.Index Terms--Genre/Form:
336502
Electronic books.
LC Class. No.: RM275
Dewey Class. No.: 616.079
National Library of Medicine Call No.: QW 940
Developing costimulatory molecules for immunotherapy of diseases[electronic resource] /
LDR
:01804nmm a2200277 a 4500
001
493651
006
m o d
007
cr cnu|unuuu||
008
210205s2015 enka ob 001 0 eng d
020
$a
9780128026755 (electronic bk.)
020
$a
0128026758 (electronic bk.)
020
$a
9780128025857
020
$a
0128025859
035
$a
(OCoLC)910324332
035
$a
ELS20100005
040
$a
N$T
$b
eng
$c
N$T
$d
EBLCP
$d
N$T
$d
CUS
$d
OPELS
$d
IDEBK
$d
YDXCP
$d
CDX
$d
OCLCF
$d
ABH
$d
OCLCQ
$d
LVT
$d
ITD
$d
OCLCO
$d
OCLCQ
$d
OCLCA
$d
U3W
$d
OCLCO
$d
D6H
$d
AU@
$d
OCLCO
$d
MERER
$d
OCLCO
$d
OCLCQ
$d
CUY
$d
OCLCQ
$d
ZCU
$d
MERUC
$d
ICG
$d
USU
$d
OCLCO
$d
DKC
$d
OCLCO
$d
OCLCQ
$d
FEM
$d
OCLCQ
$d
UHL
$d
OCLCQ
$d
UKMGB
$d
OCLCQ
$d
E7B
$d
WYU
$d
LOA
$d
K6U
$d
COCUF
$d
VT2
$d
GZM
$d
OCLCA
$d
VLY
041
0
$a
eng
050
4
$a
RM275
060
4
$a
QW 940
082
0 4
$a
616.079
$2
23
100
1
$a
Mir, Manzoor Ahmad,
$e
author.
$3
716284
245
1 0
$a
Developing costimulatory molecules for immunotherapy of diseases
$h
[electronic resource] /
$c
Manzoor Ahmad Mir.
260
$a
London :
$b
Academic Press is an imprint of Elsevier,
$c
©2015.
300
$a
1 online resource :
$b
col. ill.
504
$a
Includes bibliographical references and index.
520
$a
Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles an.
588
0
$a
Online resource; title from PDF title page (Ebsco, viewed June 3, 2015).
650
0
$a
Immunologic diseases
$x
Treatment.
$3
716285
650
0
$a
Cellular therapy.
$3
427871
650
0
$a
Immunotherapy.
$3
428279
650
1 2
$a
Immunotherapy
$x
methods.
$3
416365
650
2 2
$a
Antibodies
$x
metabolism
$3
716286
650
2 2
$a
B7 Antigens
$x
metabolism.
$3
716287
650
2 2
$a
Antigen-Antibody Reactions
$x
immunology.
$3
716288
655
4
$a
Electronic books.
$2
local
$3
336502
856
4 0
$u
https://www.sciencedirect.com/science/book/9780128025857
筆 0 讀者評論
多媒體
多媒體檔案
https://www.sciencedirect.com/science/book/9780128025857
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入